Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.
Contact us for detailed pricing information tailored to your specific needs and use cases.
Invitris partners with other companies to create and manufacture new products. Our team specializes in:
Our expertise spans across various industries, including human health, agriculture, animal health, food, and industrial chemistry.
Next-generation DNA synthesis using enzymes
Kernal is creating mRNA 2.0 therapies that work in specific cells
Make undruggable targets a thing of the past
Using protein coupling to build new therapies
AI platform accelerating therapies for rare & inflammatory diseases.
Empowering Mass Spec for Biotech and Beyond
We teach your immune system to attack and cure cancer
mRNA Immunotherapies to Eliminate Cancer
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS